Churg-Strauss syndrome epidemiology and demographics: Difference between revisions
Line 4: | Line 4: | ||
{{CMG}}{{APM}}{{AE}}{{CK}} | {{CMG}}{{APM}}{{AE}}{{CK}} | ||
==Overview== | ==Overview== | ||
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year, with higher prevalences seen in Europeans.<ref name="pmid14872461" | The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year, with higher prevalences seen in Europeans.<ref name="pmid14872461" /> | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 16 per 100,000 individuals.<ref name=" | The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 16 per 100,000 individuals .<ref name="pmid14872461">{{cite journal| author=Mahr A, Guillevin L, Poissonnet M, Aymé S| title=Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. | journal=Arthritis Rheum | year= 2004 | volume= 51 | issue= 1 | pages= 92-9 | pmid=14872461 | doi=10.1002/art.20077 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14872461 }} </ref><ref name="pmid254049302">{{cite journal| author=Gioffredi A, Maritati F, Oliva E, Buzio C| title=Eosinophilic granulomatosis with polyangiitis: an overview. | journal=Front Immunol | year= 2014 | volume= 5 | issue= | pages= 549 | pmid=25404930 | doi=10.3389/fimmu.2014.00549 | pmc=4217511 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25404930 }}</ref> | ||
===Incidence=== | ===Incidence=== | ||
The incidence of Eosinophilic granulomatosis with polyangiitis range from | The incidence of Eosinophilic granulomatosis with polyangiitis range from 0.5 to 6.8 per 100,000 individuals.<ref name="pmid25404930">{{cite journal| author=Gioffredi A, Maritati F, Oliva E, Buzio C| title=Eosinophilic granulomatosis with polyangiitis: an overview. | journal=Front Immunol | year= 2014 | volume= 5 | issue= | pages= 549 | pmid=25404930 | doi=10.3389/fimmu.2014.00549 | pmc=4217511 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25404930 }}</ref> | ||
==Demographics== | ==Demographics== | ||
===Age=== | ===Age=== |
Revision as of 19:40, 3 April 2018
Churg-Strauss syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Churg-Strauss syndrome epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Churg-Strauss syndrome epidemiology and demographics |
Churg-Strauss syndrome epidemiology and demographics in the news |
Blogs on Churg-Strauss syndrome epidemiology and demographics |
Risk calculators and risk factors for Churg-Strauss syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [3]
Overview
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year, with higher prevalences seen in Europeans.[1]
Epidemiology and Demographics
Prevalence
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 16 per 100,000 individuals .[1][2]
Incidence
The incidence of Eosinophilic granulomatosis with polyangiitis range from 0.5 to 6.8 per 100,000 individuals.[3]
Demographics
Age
The mean age at diagnosis of eosinophilic granulomatosis with polyangiitis is around 45-50 years.
Gender
In general, there is no gender predilection to Eosinophilic granulomatosis with polyangiitis in western nations. In Japan, female predominance has been noted.[4]
Race
In general, there is no racial predominance to eosinophilic granulomatosis with polyangiitis.
References
- ↑ 1.0 1.1 Mahr A, Guillevin L, Poissonnet M, Aymé S (2004). "Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate". Arthritis Rheum. 51 (1): 92–9. doi:10.1002/art.20077. PMID 14872461.
- ↑ Gioffredi A, Maritati F, Oliva E, Buzio C (2014). "Eosinophilic granulomatosis with polyangiitis: an overview". Front Immunol. 5 ( ): 549. doi:10.3389/fimmu.2014.00549. PMC 4217511. PMID 25404930.
- ↑ Gioffredi A, Maritati F, Oliva E, Buzio C (2014). "Eosinophilic granulomatosis with polyangiitis: an overview". Front Immunol. 5 ( ): 549. doi:10.3389/fimmu.2014.00549. PMC 4217511. PMID 25404930.
- ↑ Sada KE, Amano K, Uehara R, Yamamura M, Arimura Y, Nakamura Y, Makino H (July 2014). "A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan". Mod Rheumatol. 24 (4): 640–4. doi:10.3109/14397595.2013.857582. PMID 24289197.